UCSF Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain
Project Number1U19AR076737-01
Contact PI/Project LeaderLOTZ, JEFFREY C.
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
The proposed UCSF Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain
(UCSF REACH) will be an interdisciplinary consortium of basic and clinical scientists dedicated to understanding
and clarifying the biopsychosocial mechanisms of chronic low back pain (cLBP). The goal of UCSF REACH
is to define chronic low back pain (cLBP) phenotypes and pain mechanisms that can lead to
effective, personalized treatments for patients across the population. A fundamental challenge for
improving lives of cLBP patients is that pain can perpetuate and worsen as a result of dynamic interaction among
several patient-specific factors. However, the principle factors and their interactions remain obscure because
they haven't been rigorously investigated in a single longitudinal cohort. REACH proposes to overcome this
obstacle by forming a linkage between researchers who study disease biology, experts who develop advanced
investigational tools and methods, scientists who analyze vast archives of clinical data, and practitioners who
actively treat patients. UCSF REACH proposes six cores: 1) Administrative Core; 2) Clinical Core; 3) Informatics
Core; 4) Bio-behavioral Core; 5) Pathophysiology Core; and 6) Physical Function and Biomechanics Core. These
cores will provide support to a single research project that is focused on the challenge of developing validated
and adoptable tools that enable comprehensive yet routine clinical assessment and treatment of CLBP patients.
REACH will also foster scientific exchange through an Enrichment Program; the curriculum includes seminars
featuring local and visiting scientists, an annual full-day retreat with the External Advisory Committee, and half-
day symposia with a rotating topic relevant to the biopsychosocial model of cLBP. Another vital component of
REACH is its Pilot/Ancillary Studies Program. This provides seed money to leverage REACH clinical data and
cores. Overall, the object of REACH is to make optimum use of all available resources to catalyze discovery and
translation of novel diagnostics and therapeutics that improve outcomes of cLBP patients.
Public Health Relevance Statement
The overall goal of this BACPAC MRC is to define chronic low back pain (cLBP) phenotypes and pain
mechanisms that can lead to effective, personalized treatments for patients across the population. To achieve
this goal, we propose three administrative cores, three research cores, and a central research project. The
central research project will: 1) validate and prioritize novel instruments that assess critical domains of the
biopsychosocial model; 2) validate patient-centered outcome measures; and 3) investigate their clinical utility
using the UCSF REACH cLBP cohorts.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdoptedAdvisory CommitteesAnatomyAncillary StudyArchivesBack PainBiologicalBiologyBiomechanicsBlood specimenBrain imagingCaliforniaChronicChronic low back painClinicClinic ActivityClinicalClinical DataClinical ResearchClinical SciencesClinical TreatmentClinical assessmentsCommon Data ElementCommunicationCommunitiesCytometryDataData SetDiagnosticDiseaseEducational CurriculumElectronic Health RecordEnrollmentEtiologyFosteringFunctional disorderFundingFutureGenomicsGoalsHospitalsImageImaging DeviceInformaticsInfrastructureInstitutesInvestigationKnowledgeLeadLongitudinal cohortLow Back PainMachine LearningMeasuresMedicineMethodsMissionModelingMonitorMotionMusculoskeletalNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOutcomeOutcome MeasurePainPathologyPathway interactionsPatient CarePatient advocacyPatient-Focused OutcomesPatientsPhenotypePhysical FunctionPopulationPrevention strategyPsychologyQuestionnairesReportingResearchResearch PersonnelResearch Project GrantsResourcesRoleSamplingScientistSeveritiesStructureSupervisionSymptomsTechnologyTherapeutic InterventionTissue SampleTissuesTranscendTranslational ResearchTranslationsUnited StatesUnited States National Institutes of HealthUniversitiesVariantVertebral columnVisitanalytical toolbiobehaviorbiopsychosocialcentral painclinical careclinical imagingclinical painclinical practicecohortdeep learningdigitaldisabilityimprovedimproved outcomeinsightinstrumentinterdisciplinary collaborationlearning strategynovelnovel diagnosticsnovel therapeuticsoutcome forecastpain patientpain processingpatient orientedpersonalized medicineprediction algorithmprescription opioidprogramspsychologicranpirnasesocialsymposiumtargeted treatmenttooltreatment optimizationtreatment responsewearable device
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
25-September-2019
Project End Date
31-August-2023
Budget Start Date
25-September-2019
Budget End Date
31-August-2023
Project Funding Information for 2019
Total Funding
$29,408,845
Direct Costs
$20,725,420
Indirect Costs
$8,683,425
Year
Funding IC
FY Total Cost by IC
2019
National Institute of Neurological Disorders and Stroke
$29,408,845
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U19AR076737-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U19AR076737-01
Patents
No Patents information available for 1U19AR076737-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U19AR076737-01
Clinical Studies
No Clinical Studies information available for 1U19AR076737-01
News and More
Related News Releases
No news release information available for 1U19AR076737-01
History
No Historical information available for 1U19AR076737-01
Similar Projects
No Similar Projects information available for 1U19AR076737-01